REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmacos Darovi S.A. DE C.V. (Mexico)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Farmacos Darovi S.A. DE C.V. Profile Updated: May 29, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Farmacos Darovi S.A. DE C.V. is a company based in Mexico, with its head office in Azcapotzalco. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on August 19, 2013. Farmacos Darovi S.A. DE C.V. currently employs 60 (2022) people. From the latest financial highlights, Farmacos Darovi S.A. DE C.V. reported a net sales revenue increase of 6.1% in 2021. During that time, Farmacos Darovi S.A. DE C.V.’s total assets decreased by 2.5%. The net profit margin of Farmacos Darovi S.A. DE C.V. decreased by 0.07% in 2021.

Headquarters
Acalotenco 237 Bodega 107, Col. San Sebastian
Azcapotzalco; Postal Code: 02040

Contact Details: Purchase the Farmacos Darovi S.A. DE C.V. report to view the information.

Website: http://www.farmacosdarovi.com.mx

Basic Information
Total Employees:
Purchase the Farmacos Darovi S.A. DE C.V. report to view the information.
Outstanding Shares:
Purchase the Farmacos Darovi S.A. DE C.V. report to view the information.
Incorporation Date:
August 19, 2013
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Farmacos Darovi S.A. DE C.V. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MXN. Absolute financial data is included in the purchased report.
Net sales revenue
6.1%
Total operating revenue
6.1%
Operating profit (EBIT)
54.12%
Net Profit (Loss) for the Period
4.92%
Total assets
-2.5%
Total equity
34.94%
Operating Profit Margin (ROS)
3.12%
Net Profit Margin
-0.07%
Return on Equity (ROE)
-9.46%
Debt to Equity Ratio
-72.76%
Quick Ratio
0.06%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?